Compare SFWL & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SFWL | NRXS |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 78.9M |
| IPO Year | 2021 | 2023 |
| Metric | SFWL | NRXS |
|---|---|---|
| Price | $0.85 | $7.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 8.0K | ★ 112.0K |
| Earning Date | 03-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | $6.06 | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $0.56 | $2.20 |
| 52 Week High | $1.29 | $9.33 |
| Indicator | SFWL | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 50.93 |
| Support Level | $0.56 | $6.92 |
| Resistance Level | $1.01 | $7.79 |
| Average True Range (ATR) | 0.06 | 0.38 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 16.21 | 73.83 |
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The company's operations are based in the PRC. Its integrated logistics solutions are comprised of three business streams: B2B freight transportation services; cloud storage services; and value-added services. The company derives maximum revenue from Transportation, followed by Warehouse storage management services. The solutions provides by the company are : Internet TV; Electronic communication; Textiles and Apparel; Automotive parts; and e-commerce.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).